Texas Diabetes Institute, University Health System
Welcome,         Profile    Billing    Logout  
 8 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DeFronzo, Ralph A
NCT02911792: Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Completed
4
72
US
Dapagliflozin, Farxiga, Metformin, Metformin-XR, Glipizide 5 MG
The University of Texas Health Science Center at San Antonio, AstraZeneca
Diabetes Mellitus, Type 2
07/23
07/23
NCT01107717: Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Completed
4
318
US
metformin\pioglitazone\exenatide, metformin, glyburide and glargine
The University of Texas Health Science Center at San Antonio, American Diabetes Association, Amylin Pharmaceuticals, LLC., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes
02/23
02/23
NCT03953963: Evaluation of Intra-Abdominal Fat Extraction Using HydraSolve T2D™ in Obese Subjects With Type 2 Diabetes

Recruiting
N/A
12
US
HydraSolve T2D™
Medality Medical
Diabetes Mellitus, Type 2, Insulin Resistance
07/21
03/22
NCT02969798: Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Recruiting
N/A
700
US
Dapagliflozin, farxiga, Saxagliptin, onglyza, Pioglitazone, actos, Metformin, glucophage
The University of Texas Health Science Center at San Antonio, American Diabetes Association, AstraZeneca, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG)
03/26
07/27

Download Options